{
    "eid": "2-s2.0-85091924654",
    "title": "Chronic fatigue and depression due to multiple sclerosis: Immune-inflammatory pathways, tryptophan catabolites and the gut-brain axis as possible shared pathways",
    "cover-date": "2020-11-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology",
            "@code": "2808",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Heidi Ormstad",
        "Cecilia Smith Simonsen",
        "Line Broch",
        "Dr Michael Maes",
        "George Anderson",
        "Elisabeth G. Celius"
    ],
    "citedby-count": 17,
    "ref-count": 131,
    "ref-list": [
        "Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms",
        "Fatigue in Multiple Sclerosis: is it related to cytokines and hypothalamic-pituitary-adrenal axis",
        "Development of a novel neuro-immune and opioid-associated fingerprint with a cross-validated ability to identify and authenticate unknown patients with major depression: far beyond differentiation, discrimination, and classification",
        "The cellular immunology of multiple sclerosis",
        "Systematic review of depression in patients with multiple sclerosis and its relationship to interferonbeta treatment",
        "Expression of the kynurenine enzymes in macrophages and microglial cells: regulation by immune modulators",
        "Combined exercise training reduces fatigue and modulates the cytokine profile of T-cells from multiple sclerosis patients in response to neuromediators",
        "Fatigue favors in vitro Th1 and Th17-like cell expansion and reduces corticoid sensitivity in MS patients",
        "Aryl hydrocarbon receptor role in co-ordinating SARS-CoV-2 entry and symptomatology: linking cytotoxicity changes in COVID-19 and cancers; modulation by racial discrimination stress",
        "How immune-inflammatory processes link cns and psychiatric disorders: classification and treatment implications",
        "Gut Dysbiosis dysregulates central and systemic homeostasis via suboptimal mitochondrial function: assessment, treatment and classification implications",
        "Inflammation-related disorders in the tryptophan catabolite pathway in depression and somatization",
        "Multiple Sclerosis: melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mitochondria in Glia and Immune Cells",
        "IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program",
        "Multiple sclerosis: mechanisms and immunotherapy",
        "Kynurenine hydroxylase: a potential rate-limiting enzyme in tryptophan metabolism",
        "Is there a link between inflammation and fatigue in multiple sclerosis",
        "Butyrate suppresses demyelination and enhances remyelination",
        "Fatigue in MS is associated with specific clinical features",
        "Progressive multiple sclerosis: from pathogenic mechanisms to treatment",
        "Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers",
        "Twenty years of research on cytokine-induced sickness behavior",
        "Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis",
        "Immunopathology of multiple sclerosis",
        "Ceramides and depression: a systematic review",
        "The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: the elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy",
        "Indoleamine 2,3-dioxygenase activation and depressive symptoms: results from the Young Finns Study",
        "Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis-Special Focus on the Peroxisome Proliferator-Activated Receptors (PPARs) and the Kynurenines",
        "Multiple Sclerosis Council For Clinical Practice Guidelines (Ed.)",
        "Multiple sclerosis",
        "The impact of fatigue on patients with multiple sclerosis",
        "Cytokine mRNA expression in patients with multiple sclerosis and fatigue",
        "The nature of fatigue in multiple sclerosis",
        "Interleukin-6 is elevated in plasma in multiple sclerosis",
        "Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism",
        "The possible role of the kynurenine pathway in adolescent depression with melancholic features",
        "Fatigue is not associated with raised inflammatory markers in multiple sclerosis",
        "Depression and immunity: inflammation and depressive symptoms in multiple sclerosis",
        "Depression and fatigue in patients with multiple sclerosis",
        "A basic overview of multiple sclerosis immunopathology",
        "Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey",
        "Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6",
        "Altered cytokine responses to cognitive stress in multiple sclerosis patients with fatigue",
        "Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour",
        "Exercise therapy for fatigue in multiple sclerosis",
        "Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation",
        "Neuroinflammation, neurodegeneration, and depression",
        "The Multiple Sclerosis Genomic Map: role of peripheral immune cells and resident microglia in susceptibility",
        "Sodium butyrate protects mice from the development of the early signs of non-alcoholic fatty liver disease: role of melatonin and lipid peroxidation",
        "Mood disorder and multiple sclerosis",
        "Expression of tumor necrosis factor-alpha and interferon-gamma mRNA in blood cells correlates with depression scores during an acute attack in patients with multiple sclerosis",
        "Immune-inflammatory and oxidative and nitrosative stress biomarkers of depression symptoms in subjects with multiple sclerosis: increased peripheral inflammation but less acute neuroinflammation",
        "Publisher Correction: common brain disorders are associated with heritable patterns of apparent aging of the brain",
        "Fatigue and sleep disturbance in multiple sclerosis",
        "Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain",
        "Soluble and cell surface ICAM-1 as markers for disease activity in multiple sclerosis",
        "Fatigue in multiple sclerosis",
        "The fatigue severity scale. application to patients with multiple sclerosis and systemic lupus erythematosus",
        "Multiple sclerosis-associated fatigue",
        "Depressive symptoms account for deficient information processing speed but not for impaired working memory in early phase multiple sclerosis (MS)",
        "Anxiogenic activity of quinolinic acid and kynurenine in the social interaction test in mice",
        "Psychometric properties of the modified fatigue impact scale",
        "A prospective study of patterns of fatigue in multiple sclerosis",
        "Fatigue and its association with sociodemographic variables among multiple sclerosis patients",
        "Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis",
        "The role of bacteria and its derived metabolites in chronic pain and depression: recent findings and research progress",
        "Impaired dexamethasone-mediated induction of tryptophan 2,3-dioxygenase in heme-deficient rat hepatocytes: translational control by a hepatic eIF2alpha kinase, the heme-regulated inhibitor",
        "Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression",
        "Fatigue in the general Norwegian population: normative data and associations",
        "Defining the clinical course of multiple sclerosis: the 2013 revisions",
        "Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways",
        "Normalization of the increased translocation of endotoxin from gram negative enterobacteria (leaky gut) is accompanied by a remission of chronic fatigue syndrome",
        "The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression",
        "Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: effects of age, duration of illness and the translocation of LPS from gram-negative bacteria",
        "Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway",
        "Fatigue in patients with multiple sclerosis: is it related to pro- and anti-inflammatory cytokines",
        "Indoleamine 2,3 Dioxygenase (IDO) expression and activity in relapsing-remitting multiple sclerosis",
        "The kynurenine system and immunoregulation",
        "Human gut-derived commensal bacteria suppress CNS inflammatory and demyelinating disease",
        "Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay",
        "IDO expression by dendritic cells: tolerance and tryptophan catabolism",
        "The role of inflammation in depression: from evolutionary imperative to modern treatment target",
        "Development of a patient reported outcome scale for fatigue in multiple sclerosis: the Neurological Fatigue Index (NFI-MS)",
        "Depression in multiple sclerosis",
        "Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases",
        "The role of the microbial metabolites including tryptophan catabolites and short chain fatty acids in the pathophysiology of immune-inflammatory and neuroimmune disease",
        "The Many Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be associated with the pathophysiology of neuro-immune disorders",
        "Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics",
        "Multiple immune-inflammatory and oxidative and nitrosative stress pathways explain the frequent presence of depression in multiple sclerosis",
        "Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis",
        "Tryptophan metabolism and immunogenetics in major depression: a role for interferon-gamma gene",
        "Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis",
        "Kynurenine pathway in major depression: evidence of impaired neuroprotection",
        "Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics",
        "Central fatigue in multiple sclerosis: a review of the literature",
        "Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis",
        "Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin",
        "3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity",
        "Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging",
        "Multiple sclerosis and fatigue: a review on the contribution of inflammation and immune-mediated neurodegeneration",
        "Longitudinal correlates of fatigue in multiple sclerosis",
        "Depression in multiple sclerosis",
        "Fatigue as a symptom or comorbidity of neurological diseases",
        "The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue",
        "Stimulated peripheral production of interferon-gamma is related to fatigue and depression in multiple sclerosis",
        "Pathology of demyelinating diseases",
        "Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases",
        "GD1a Overcomes Inhibition of Myelination by Fibronectin via Activation of Protein Kinase A: implications for Multiple Sclerosis",
        "Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms",
        "Aryl hydrocarbon receptor control of adaptive immunity",
        "Multiple Sclerosis, Gut Microbiota and Permeability: role of Tryptophan Catabolites, Depression and the Driving Down of Local Melatonin",
        "Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis",
        "Depression and multiple sclerosis",
        "Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis",
        "The gut microbiota in multiple sclerosis: an overview of clinical trials",
        "Kynurenines in the mammalian brain: when physiology meets pathology",
        "Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor",
        "Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis",
        "Subgroups of multiple sclerosis patients with larger treatment benefits: a meta-analysis of randomized trials",
        "Psychological stress and cytokine production in multiple sclerosis: correlation with disease symptomatology",
        "Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS",
        "Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors",
        "Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism",
        "The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects",
        "Tryptophan catabolites and their impact on multiple sclerosis progression",
        "Environmental and genetic risk factors for MS: an integrated review",
        "IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity",
        "Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme",
        "Pharmacological treatments for fatigue in patients with multiple sclerosis: a systematic review and meta-analysis",
        "Evaluation of variation in genes of the arylhydrocarbon receptor pathway for an association with multiple sclerosis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Kongsberg",
            "@id": "60111747",
            "affilname": "University of South-Eastern Norway",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60111747",
            "affiliation-country": "Norway"
        },
        {
            "affiliation-city": "Oslo",
            "@id": "60105037",
            "affilname": "Oslo Universitetssykehus",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60105037",
            "affiliation-country": "Norway"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "London",
            "@id": "123412614",
            "affilname": "CRC Scotland &amp; London",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/123412614",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Drammen",
            "@id": "119888886",
            "affilname": "Vestre Viken Hospital Trust",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/119888886",
            "affiliation-country": "Norway"
        }
    ],
    "funding": []
}